Results 141 to 150 of about 38,934 (294)

In Situ pH Determination Using 1H‐MRS Acetate Chemical Shift for Noninvasive Postmortem Examinations

NMR in Biomedicine, Volume 39, Issue 7, July 2026.
The chemical‐shift difference between acetate and myo‐inositol measured by MRS enables estimation of pH in the acidic range. Noninvasive pH assessment in forensic investigations is demonstrated in 58 cases and validated by measurements in extracted tissue.
Sabina Frese, Dominic Gascho, Michael J. Thali, Sebastian Kozerke, Niklaus Zoelch   +4 more
wiley   +1 more source

A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor‐Associated Ketoacidosis Case Reports

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Introduction The use of sodium–glucose cotransporter‐2 inhibitors (SGLT2i) in the perioperative setting may lead to SGLT2i‐associated postoperative ketoacidosis (SAPKA) in patients with type 2 diabetes (T2D). Therefore, cessation of this drug is recommended before surgery.
L. I. P. Snel, X. Li, F. Jamaludin, S. E. Siegelaar, F. Holleman, T. M. Vriesendorp, J. H. DeVries, J. B. L. Hoekstra, B. Preckel, D. H. van Raalte, J. Hermanides, A. H. Hulst   +11 more
wiley   +1 more source

A consensus statement on a National Competency Framework for training and assessment of knowledge and skills in diabetes technologies, including hybrid closed loop (HCL), insulin pump systems, and continuous glucose monitoring (CGM) devices

Diabetic Medicine, Volume 43, Issue 7, July 2026.
Abstract Aims To design a national competency framework supporting the training of healthcare professionals (HCP) in the care and management of people with diabetes using diabetes technologies. Methods Following the release of the NICE [TA943] guidance1 and the NHS England 5‐year implementation strategy2, a working group was formed to design a four ...
E. Richardson, B. Stribling, J. Ridgeway, C. Kitching‐Davis, L. Willcocks, L. Heggs, H. Wakefield, G. Gallen, A. Jolley, K. Bareford, A. Williams, D. Farrow, T. Fletcher‐Salt, D. Hicks, J. Higgins, L. Jordan, B. Kelly, C. Metcalf‐O’Shea, M. Turner, E. Walden, A. Walker, P. Choudhary   +21 more
wiley   +1 more source

Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio‐economic areas

Diabetic Medicine, Volume 43, Issue 7, July 2026.
Abstract Aims Access to diabetes technology in the UK is significantly influenced by socio‐economic status, ethnicity, and systemic healthcare inequities. This study investigates barriers faced by children and young people (CYP) from ethnic minority backgrounds and/or low socio‐economic areas in accessing diabetes technologies, alongside strategies for
Eda Tonga, Mark Evans, Nick Oliver, Sze May Ng, Natalie Darko   +4 more
wiley   +1 more source

Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes—The INTERFAST‐3 study design

Diabetic Medicine, Volume 43, Issue 7, July 2026.
Abstract Aims Lifestyle modification, including caloric restriction and exercise, is fundamental in the treatment of people living with overweight and type 2 diabetes mellitus (T2D). The overall aim of lifestyle intervention schemes is to reduce body weight and improve glycaemic control to reduce the future risk of diabetes‐associated complications ...
Caren Sourij, Alexander Müller, Abdullah Al‐Baghdadi, Faisal Aziz, Norbert J. Tripolt, Peter N. Pferschy, Eva Andritz, Harald Kojzar, Vanessa Stadlbauer, Sabrina Leal Garcia, Harald Sourij   +10 more
wiley   +1 more source

A systematic review and meta‐analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D)

Diabetic Medicine, Volume 43, Issue 7, July 2026.
Abstract Introduction Achieving and sustaining target glycated haemoglobin (HbA1c) levels is fundamental in the management of type 2 diabetes (T2D). We here aimed to assess whether initial dual oral therapy outperforms monotherapy in reaching glycaemic targets in patients with treatment‐naive or early‐stage T2D.
Mairead Kelly, Sushant Saluja, Hugh Logan Ellis, Sarah Jamil, Martin B. Whyte, Adrian Heald   +5 more
wiley   +1 more source

Cost‐Effectiveness of Control‐IQ+ Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6280-6290, July 2026.
ABSTRACT Objective Automated insulin delivery (AID) has been established as an effective therapy for individuals with type 1 diabetes. This analysis evaluates the clinical and economic outcomes of AID compared with multiple daily injections plus continuous glucose monitoring (MDI/CGM) in adults with type 2 diabetes. Materials and Methods The IQVIA CORE
Neda Al Rawashdh, Bimal V. Patel, Sharon M. Wang, Richard M. Zur, Pablo Anaya, Emily B. Kahn, Jordan E. Pinsker, Ravid Sasson‐Katchalski, Alex C. Trahan, Laurel H. Messer, Kimia Assadi, Yogish C. Kudva, Roy W. Beck   +12 more
wiley   +1 more source

Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5740-5750, July 2026.
ABSTRACT Aims Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) improve glycaemic control and cardiorenal outcomes in Type 2 diabetes, particularly in patients at elevated cardiovascular and kidney risk, yet discontinuation following infections appears common.
Christine Ljungberg, Mette Nørgaard, Christina Vandenbroucke‐Grauls, Michael Dalager‐Pedersen, Henrik Toft Sørensen, Reimar Wernich Thomsen   +5 more
wiley   +1 more source

Euglycemic Diabetic Ketoacidosis-Like State During the Treatment of Diabetic Ketoacidosis in Fulminant Type 1 Diabetes: A Case Report. [PDF]

Cureus
Yamauchi K.
europepmc   +1 more source

Cerebral complications in diabetic ketoacidosis

, 2005
Although much is known about diabetic ketoacidosis (DKA) and its treatment, the pathology of cerebral complications in patients who develop ketoacidosis is not yet well understood.
Sükrü Hatun, Filiz Cizmecioğlu, Demet Toprak   +2 more
core